Doxazosin-carrageenan interactions: A novel approach for studying drug-polymer interactions and relation to controlled drug release

被引:40
|
作者
Pavli, Matej [2 ,3 ]
Baumgartner, Sasa [2 ]
Kos, Petra [2 ]
Kogej, Ksenija [1 ]
机构
[1] Univ Ljubljana, Dept Chem & Biochem, Fac Chem & Chem Technol, SI-1001 Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Pharm, SI-1000 Ljubljana, Slovenia
[3] Krka Dd, SI-8501 Novo Mesto, Slovenia
关键词
Drug-polymer interactions; Binding isotherms; Electrostatic interactions; Cooperativity; Hydrophobic effect; Controlled release; KAPPA-CARRAGEENAN; AQUEOUS-SOLUTION; STRUCTURAL CHARACTERISTICS; AMPHIPHILE INTERACTION; IOTA-CARRAGEENAN; DEXTRAN SULFATE; CHARGE-DENSITY; MATRIX TABLETS; SURFACTANT; BINDING;
D O I
10.1016/j.ijpharm.2011.09.019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
When a cationic drug like doxazosin mesylate (DM) is incorporated into matrix tablets made of anionic polyelectrolytes carrageenans (CARRs) of different types (kappa-, iota-, lambda-CARR), DM-CARR interactions have a strong impact on drug release. To investigate these interactions, special DM ion-selective membrane electrode was made and applied for construction of binding isotherms. Isotherms were treated by the Zimm-Bragg theory and cooperative binding model. It was demonstrated that binding of doxazosin cations, DN+, to CARRs is cooperative. It starts at very low drug concentrations with strong electrostatic interactions followed by aggregation of DH+ ions. Hydrophobic interactions between bound DH+ substantially contribute to the extent of binding. The strength of interactions increases with increasing negative charge of CARRs. At saturation, the number of DM molecules bound per repeat unit depends on the charge and steric distribution of binding sites on CARRs. Drug release rates of DM from CARR matrices were in accordance with the cooperativity binding constants: the weakest binding resulted in the fastest release. However it was proven that prolonged drug release is possible only by several processes running simultaneously, i.e., by swelling and erosion of CARR matrices on one side and electrostatic interactions and cooperativity effects on the other. (C) 2011 Elsevier B.V. All rights reserved.
引用
下载
收藏
页码:110 / 119
页数:10
相关论文
共 50 条
  • [1] Predicting drug-polymer interactions
    Rahman, S.
    Uchegbu, I. F.
    Johnston, B.
    Mackay, S.
    Schatzlein, A. G.
    Gellert, P.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2005, 57 : S52 - S53
  • [2] Polymer-Mediated Drug Supersaturation Controlled by Drug-Polymer Interactions Persisting in an Aqueous Environment
    Chen, Yuejie
    Pui, Yipshu
    Chen, Huijun
    Wang, Shan
    Serno, Peter
    Tonnis, Wouter
    Chen, Linc
    Qian, Feng
    MOLECULAR PHARMACEUTICS, 2019, 16 (01) : 205 - 213
  • [3] Polysaccharide nanoparticles for oral controlled drug delivery: the role of drug-polymer and interpolymer interactions
    Bianchera, Annalisa
    Bettini, Ruggero
    EXPERT OPINION ON DRUG DELIVERY, 2020, 17 (10) : 1345 - 1359
  • [4] The influence of drug-polymer interactions on release of antirestenotic agent from bioresorbable scaffolds
    Jelonek, Katarzyna
    Kaczmarczyk, Bozena
    Jaworska, Joanna
    Pastusiak, Malgorzata
    Sobota, Michal
    Dobrzynski, Piotr
    Kasperczyk, Janusz
    MATERIALS LETTERS, 2018, 223 : 82 - 85
  • [5] Effects of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets
    Pajander, J.
    Laamanen, M.
    Grimsey, I.
    Korhonen, O.
    van Veen, B.
    Ketolainen, J.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (01) : S31 - S31
  • [6] Effect of Formulation Parameters and Drug-Polymer Interactions on Drug Release from Starch Acetate Matrix Tablets
    Pajander, Jari
    Korhonen, Ossi
    Laamanen, Maria
    Ryynanen, Eeva-Leena
    Grimsey, Ian
    Van Veen, Bert
    Ketolainen, Jarkko
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (10) : 3676 - 3690
  • [7] In silico modelling of drug-polymer interactions for pharmaceutical formulations
    Ahmad, Samina
    Johnston, Blair F.
    Mackay, Simon P.
    Schatzlein, Andreas G.
    Gellert, Paul
    Sengupta, Durba
    Uchegbu, Ijeoma F.
    JOURNAL OF THE ROYAL SOCIETY INTERFACE, 2010, 7 : S423 - S433
  • [8] Strength of Drug-Polymer Interactions: Implications for Crystallization in Dispersions
    Mistry, Pinal
    Suryanarayanan, Raj
    CRYSTAL GROWTH & DESIGN, 2016, 16 (09) : 5141 - 5149
  • [9] STUDIES OF DRUG-POLYMER INTERACTIONS OF SIMVASTATIN WITH VARIOUS POLYMERS
    Bal, Trishna
    Murthy, P. N.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (02): : 561 - 563
  • [10] Advances in oral controlled drug delivery: the role of drug-polymer and interpolymer non-covalent interactions
    De Robertis, Simona
    Bonferoni, Maria Cristina
    Elviri, Lisa
    Sandri, Giuseppina
    Caramella, Carla
    Bettini, Ruggero
    EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (03) : 441 - 453